ACH
LYRA

ArrowMark Colorado Holdings’s LYRA THERAPEUTICS INC LYRA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,784
Closed -$1.27M – 356
2021
Q3 		$1.27M Hold
2,784
– – 0.01% 300
2021
Q2 		$1.12M Hold
2,784
– – 0.01% 295
2021
Q1 		$1.61M Sell
2,784
-12,734
-82% -$7.96M 0.01% 287
2020
Q4 		$8.85M Sell
15,518
-246
-2% -$139K 0.07% 187
2020
Q3 		$8.81M Buy
15,764
+11,760
+294% +$7.31M 0.08% 162
2020
Q2 		$2.27M Buy
+4,004
New +$2.93M 0.02% 225

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ArrowMark Colorado Holdings's LYRA Position: Q4 2021 in Review

ArrowMark Colorado Holdings sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 2,784 shares — an estimated $1.27M sold.

ArrowMark Colorado Holdings first reported a position in LYRA in Q2 2020 and held it in 6 quarters. The position peaked at $8.85M in Q4 2020. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

  • ArrowMark Colorado Holdings reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 2,784 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $1.27M.
  • ArrowMark Colorado Holdings first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 6 quarters.
  • ArrowMark Colorado Holdings's LYRA THERAPEUTICS INC position peaked at $8.85M in Q4 2020.
  • 33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.